Skip to content

Verge Genomics

YC S15 · Active · We use human data and AI to develop better drugs faster.

Competitors

Adjacent

Also from S15 in AI

All of S15

About Verge Genomics

Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.

YC batch
S15 · Summer 2015
Status, per YC
Active
Category
AI
Team size
50
Location
San Francisco, CA, USA
Checked
35m ago

Verge Genomics in S15: 104 companies, 20% AI

Verge Genomics: questions

Which YC batch was Verge Genomics in?

Verge Genomics was in Y Combinator's Summer 2015 batch (S15).

Is Verge Genomics still active?

Y Combinator lists Verge Genomics as active.

Where is Verge Genomics based?

Verge Genomics lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.